126 related articles for article (PubMed ID: 35931920)
1. Deposition of platelet-derived microparticles in podocytes contributes to diabetic nephropathy.
Huang SJ; Zhang Y; Wang GH; Lu J; Chen PP; Zhang JX; Li XQ; Yuan BY; Liu XQ; Jiang TT; Wang MY; Liu WT; Ruan XZ; Liu BC; Ma KL
Int Urol Nephrol; 2023 Feb; 55(2):355-366. PubMed ID: 35931920
[TBL] [Abstract][Full Text] [Related]
2. GPR43 deficiency protects against podocyte insulin resistance in diabetic nephropathy through the restoration of AMPKα activity.
Lu J; Chen PP; Zhang JX; Li XQ; Wang GH; Yuan BY; Huang SJ; Liu XQ; Jiang TT; Wang MY; Liu WT; Ruan XZ; Liu BC; Ma KL
Theranostics; 2021; 11(10):4728-4742. PubMed ID: 33754024
[No Abstract] [Full Text] [Related]
3. Inflammatory stress exacerbates lipid accumulation and podocyte injuries in diabetic nephropathy.
Zhang Y; Ma KL; Liu J; Wu Y; Hu ZB; Liu L; Lu J; Zhang XL; Liu BC
Acta Diabetol; 2015 Dec; 52(6):1045-56. PubMed ID: 25896009
[TBL] [Abstract][Full Text] [Related]
4. Aspirin attenuates podocyte injury in diabetic rats through overriding cyclooxygenase-2-mediated dysregulation of LDL receptor pathway.
Ma KL; Liu L; Zhang Y; Wang GH; Hu ZB; Chen PP; Lu J; Lu CC; Gong TK; Gong YX; Liu BC
Int Urol Nephrol; 2019 Mar; 51(3):551-558. PubMed ID: 30604228
[TBL] [Abstract][Full Text] [Related]
5. Sweroside attenuates podocyte injury and proteinuria in part by activating Akt/BAD signaling in mice.
Huang M; Yang Y; Chen Y; Li Y; Qin S; Xiao L; Long X; Hu K; Li Y; Ying H; Ding Y
J Cell Biochem; 2023 Nov; 124(11):1749-1763. PubMed ID: 37796169
[TBL] [Abstract][Full Text] [Related]
6. MAD2B promotes podocyte injury through regulating Numb-dependent Notch 1 pathway in diabetic nephropathy.
Li MR; Lei CT; Tang H; Yin XJ; Hao Z; Qiu Y; Xie YR; Zeng JY; Su H; Zhang C
Int J Biol Sci; 2022; 18(5):1896-1911. PubMed ID: 35342338
[No Abstract] [Full Text] [Related]
7. Dysregulation of low-density lipoprotein receptor contributes to podocyte injuries in diabetic nephropathy.
Zhang Y; Ma KL; Liu J; Wu Y; Hu ZB; Liu L; Liu BC
Am J Physiol Endocrinol Metab; 2015 Jun; 308(12):E1140-8. PubMed ID: 25921580
[TBL] [Abstract][Full Text] [Related]
8. Mangiferin prevents diabetic nephropathy progression and protects podocyte function via autophagy in diabetic rat glomeruli.
Wang X; Gao L; Lin H; Song J; Wang J; Yin Y; Zhao J; Xu X; Li Z; Li L
Eur J Pharmacol; 2018 Apr; 824():170-178. PubMed ID: 29444469
[TBL] [Abstract][Full Text] [Related]
9. GPR43 activation-mediated lipotoxicity contributes to podocyte injury in diabetic nephropathy by modulating the ERK/EGR1 pathway.
Lu J; Chen PP; Zhang JX; Li XQ; Wang GH; Yuan BY; Huang SJ; Liu XQ; Jiang TT; Wang MY; Liu WT; Ruan XZ; Liu BC; Ma KL
Int J Biol Sci; 2022; 18(1):96-111. PubMed ID: 34975320
[No Abstract] [Full Text] [Related]
10. Knockdown of Angiopoietin-Like Protein 2 Ameliorates Diabetic Nephropathy by Inhibiting TLR4.
Yang S; Zhang J; Wang S; Shi J; Zhao X
Cell Physiol Biochem; 2017; 43(2):685-696. PubMed ID: 28946139
[TBL] [Abstract][Full Text] [Related]
11. MiR-21-5p in macrophage-derived extracellular vesicles affects podocyte pyroptosis in diabetic nephropathy by regulating A20.
Ding X; Jing N; Shen A; Guo F; Song Y; Pan M; Ma X; Zhao L; Zhang H; Wu L; Qin G; Zhao Y
J Endocrinol Invest; 2021 Jun; 44(6):1175-1184. PubMed ID: 32930981
[TBL] [Abstract][Full Text] [Related]
12. Protein S Protects against Podocyte Injury in Diabetic Nephropathy.
Zhong F; Chen H; Xie Y; Azeloglu EU; Wei C; Zhang W; Li Z; Chuang PY; Jim B; Li H; Elmastour F; Riyad JM; Weber T; Chen H; Wang Y; Zhang A; Jia W; Lee K; He JC
J Am Soc Nephrol; 2018 May; 29(5):1397-1410. PubMed ID: 29511111
[No Abstract] [Full Text] [Related]
13. The novel role of TRPC6 in vitamin D ameliorating podocyte injury in STZ-induced diabetic rats.
Zhang X; Song Z; Guo Y; Zhou M
Mol Cell Biochem; 2015 Jan; 399(1-2):155-65. PubMed ID: 25292315
[TBL] [Abstract][Full Text] [Related]
14. Effects of angiotensin receptor blocker on phenotypic alterations of podocytes in early diabetic nephropathy.
Dai HY; Zheng M; Tang RN; Ni J; Ma KL; Li Q; Liu BC
Am J Med Sci; 2011 Mar; 341(3):207-14. PubMed ID: 21326079
[TBL] [Abstract][Full Text] [Related]
15. Hyperoside reduces albuminuria in diabetic nephropathy at the early stage through ameliorating renal damage and podocyte injury.
Zhang J; Fu H; Xu Y; Niu Y; An X
J Nat Med; 2016 Oct; 70(4):740-8. PubMed ID: 27255369
[TBL] [Abstract][Full Text] [Related]
16. Astragaloside IV attenuates proteinuria in streptozotocin-induced diabetic nephropathy via the inhibition of endoplasmic reticulum stress.
Wang ZS; Xiong F; Xie XH; Chen D; Pan JH; Cheng L
BMC Nephrol; 2015 Mar; 16():44. PubMed ID: 25886386
[TBL] [Abstract][Full Text] [Related]
17. Podocyte RNF166 deficiency alleviates diabetic nephropathy by mitigating mitochondria impairment and apoptosis via regulation of CYLD signal.
Hongbo M; Yanjiao D; Shuo W; Kun S; Yanjie L; Mengmeng L
Biochem Biophys Res Commun; 2021 Mar; 545():46-53. PubMed ID: 33545631
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-503 contributes to podocyte injury via targeting E2F3 in diabetic nephropathy.
Zha F; Bai L; Tang B; Li J; Wang Y; Zheng P; Ji T; Bai S
J Cell Biochem; 2019 Aug; 120(8):12574-12581. PubMed ID: 30834596
[TBL] [Abstract][Full Text] [Related]
19. Astragaloside IV ameliorates diabetic nephropathy involving protection of podocytes in streptozotocin induced diabetic rats.
Chen J; Chen Y; Luo Y; Gui D; Huang J; He D
Eur J Pharmacol; 2014 Aug; 736():86-94. PubMed ID: 24809932
[TBL] [Abstract][Full Text] [Related]
20. Diabetes-Induced DUSP4 Reduction Promotes Podocyte Dysfunction and Progression of Diabetic Nephropathy.
Denhez B; Rousseau M; Dancosst DA; Lizotte F; Guay A; Auger-Messier M; Côté AM; Geraldes P
Diabetes; 2019 May; 68(5):1026-1039. PubMed ID: 30862678
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
